Patent CA2752908A1 - Treatment of insulin-resistant disorders - Google Patente
The invention concerns the treatment of insulin-resistant disorders. In particular, the invention concerns the treatment of insulin-resistant disorders by administration of IL-17, such as IL-17 A and/or IL- 17F antagonists, such as anti-IL-17A and/or IL- 17F and/or IL- 17Rc antibodies, or antibody fragments.
Patent WO2012006633A1 - Chimeric clotting factors - Google Patente
Chimeric clotting factors which localize the therapeutic to sites of coagulation (e.g., by being targeted to platelets or being activatable at sites of coagulation), have reduced clearance rates, have improved manufacturability, have reduced thrombogenicity, have enhanced activity, or have more than one of these characteristics are described as are methods for making chimeric clotting factors and methods for improving hemostasia using these clotting factors.
The Misfits: Ashy's Storyhour! (updated 06/06/05) | Planewalker
Jekka chuckled, patting her simple-minded cohort on the head, “Ug ... It seemed
to the fey'ri that everyone and everything within those ..... I have the authority to claim any unattended structure as my own, to do with as I see fit.
family member pdf - The Lens
NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID - Patent application
25 Feb 2010 ... The method of claim 1, wherein the at least one analogue or fragment of ... the
effective amount of the polypeptide is between about 1.5 ug and 2,000 ug. ......
Especially conjugates between antigen and anti-FeyRI have been ...